Cargando…
Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1988
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246673/ https://www.ncbi.nlm.nih.gov/pubmed/3348944 |
| _version_ | 1782150817595260928 |
|---|---|
| author | Osborne, R. J. Malik, S. T. Slevin, M. L. Harvey, V. J. Spona, J. Salzer, H. Williams, C. J. |
| author_facet | Osborne, R. J. Malik, S. T. Slevin, M. L. Harvey, V. J. Spona, J. Salzer, H. Williams, C. J. |
| author_sort | Osborne, R. J. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2246673 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1988 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22466732009-09-10 Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. Osborne, R. J. Malik, S. T. Slevin, M. L. Harvey, V. J. Spona, J. Salzer, H. Williams, C. J. Br J Cancer Research Article Nature Publishing Group 1988-01 /pmc/articles/PMC2246673/ /pubmed/3348944 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Osborne, R. J. Malik, S. T. Slevin, M. L. Harvey, V. J. Spona, J. Salzer, H. Williams, C. J. Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. |
| title | Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. |
| title_full | Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. |
| title_fullStr | Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. |
| title_full_unstemmed | Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. |
| title_short | Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. |
| title_sort | tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246673/ https://www.ncbi.nlm.nih.gov/pubmed/3348944 |
| work_keys_str_mv | AT osbornerj tamoxifeninrefractoryovariancancertheuseofaloadingdoseschedule AT malikst tamoxifeninrefractoryovariancancertheuseofaloadingdoseschedule AT slevinml tamoxifeninrefractoryovariancancertheuseofaloadingdoseschedule AT harveyvj tamoxifeninrefractoryovariancancertheuseofaloadingdoseschedule AT sponaj tamoxifeninrefractoryovariancancertheuseofaloadingdoseschedule AT salzerh tamoxifeninrefractoryovariancancertheuseofaloadingdoseschedule AT williamscj tamoxifeninrefractoryovariancancertheuseofaloadingdoseschedule |